Seeing Is Believing

Currently out of the existing stock ratings of Charles Rhyee, 292 are a BUY (73%), 103 are a HOLD (25.75%), 5 are a SELL (1.25%).
Analyst Charles Rhyee, currently employed at TD COWEN, carries an average stock price target met ratio of 67.86% that have a potential upside of 27.3% achieved within 264 days. Previously, Charles Rhyee worked at COWEN.
Charles Rhyee’s has documented 803 price targets and ratings displayed on 52 stocks. The coverage is on Healthcare, Consumer Cyclical, Communication Services, Energy sectors.
Most recent stock forecast was given on MEDP, Medpace Holdings at 24-Jul-2026.
Analyst best performing recommendations are on CSLT (CASTLIGHT HEALTH).
The best stock recommendation documented was for FTRE (FORTREA HOLDINGS) at 8/11/2025. The price target of $7 was fulfilled within 1 day with a profit of $0.61 (9.55%) receiving and performance score of 95.46.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 27-Feb-2018
$215
$40.04 (22.89%)
$187
2 years 11 months 25 days ago
(07-Aug-2023)
15/16 (93.75%)
$28.91 (15.54%)
636
Hold Since 27-May-2022
$190
$15.04 (8.60%)
$176
2 years 11 months 29 days ago
(03-Aug-2023)
12/12 (100%)
$-0.86 (-0.45%)
392
Buy Since 11-Oct-2022
$215
$40.04 (22.89%)
$200
2 years 11 months 29 days ago
(03-Aug-2023)
7/10 (70%)
$24.14 (12.65%)
211
Buy Since 05-Aug-2021
$220
$45.04 (25.74%)
$213
2 years 11 months 29 days ago
(03-Aug-2023)
11/17 (64.71%)
$29.14 (15.27%)
326
$190
$15.04 (8.60%)
2 years 11 months 29 days ago
(03-Aug-2023)
9/9 (100%)
$-0.86 (-0.45%)
440
Which stock is Charles Rhyee is most bullish on?
Which stock is Charles Rhyee is most reserved on?
What Year was the first public recommendation made by Charles Rhyee?